CASI News and Press, CASI Pharmaceuticals Inc. From 12/20/20

Will These Penny Stocks Reach New Highs Before Next Year? Looking for penny stocks to buy can be easier said than done. One of the main reasons is that emotions can easily impact when and how you buy or sell. Simply put, it isn’t uncommon to see these cheap stocks race higher...

CASI Pharmaceuticals (CASI) appoints Weihao Xu to the position of Chief Financial Officer. Mr. Xu will report to Dr. Wei-Wu He, Chairman and CEO of CASI.Most recently, in January 2020, Mr. Xu founded and served as Chief Investment Officer for Permanence Capital, a healthcare-dedicated investm...

CASI Pharmaceuticals Announces Appointment Of Chief Financial Officer ROCKVILLE, Md. , and BEIJING , Dec. 16, 2020 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therape...

Insider buying increased last week with insiders purchasing $84.63 million of stock. Notable Insider Buys: Coty Inc., Danaher Corporation, Urban One, Inc., Alaska Communications Systems Group, Inc., and CASI Pharmaceuticals, Inc. Notable Insider Sells: Berkeley Lights, Inc., Faceb...

AnPac Bio-Medical Science (ANPC) +95% on Q3 record test volume.Mmtec (MTC) +50%.Yunji (YJ) +46% on deal with Bytedance's live streaming platform.Weidai (WEI) +30%.Safe-T Group Ltd (SFET) +22% on Q3 results.Molecular Data (MKD) +22%.21Vianet Group (VNET) +20%...

Casi Pharmaceuticals (CASI) CEO Wei-Wu He buys 227.5K shares of common stock on November 20, in a total transaction size of $488.Form 4. For further details see: Casi Pharmaceuticals jumps 6% after CEO buys 227.5K shares

CASI Pharmaceuticals' (CASI) partner Juventas has completed $65M financing and has initiated and enrolled the first patient in a Phase II registration study for CNCT19 (CD19 CAR-T) in China in patients with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL). Juventas expects to start ...

CASI Pharmaceuticals Announces Partner Juventas Completes $65 Million Financing And Initiates Registration Study For CNCT19 (CD19 CAR-T) CASI to Co-Commercialize CNCT19, with Additional Rights to a Second Product from Juventas' Cell Therapy Pipeline PR Newswire ROCKVILLE...

CASI Pharmaceuticals, Inc. (CASI) Q3 2020 Earnings Conference Call November 9, 2020 16:30 ET Company Participants Cynthia Hu - General Counsel & Secretary Wei-Wu He - Chairman & Chief Executive Officer Alex Zukiwski - Chief Medical Officer Jim Goldschmidt - Senior Vice President Confe...

Image source: The Motley Fool. CASI Pharmaceuticals Inc (NASDAQ: CASI) Q3 2020 Earnings Call Nov 9, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: CASI Pharmaceuticals Inc (CASI) Q3 2020 Earnings Call Transcript